Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: 323990)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,720
+60 (0.56%)
Jan 21, 2025, 9:00 AM KST
-45.56%
Market Cap 246.49B
Revenue (ttm) 69.60M
Net Income (ttm) -10.43B
Shares Out 22.99M
EPS (ttm) -444.28
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 934,885
Average Volume 126,536
Open 11,050
Previous Close 10,660
Day's Range 10,700 - 12,490
52-Week Range 9,980 - 25,200
Beta 3.39
RSI 44.70
Earnings Date n/a

About Vaxcell-Bio Therapeutics

Vaxcell-Bio Therapeutics Co., Ltd. develops and sells cancer immune cell therapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 323990
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.